The Indian equity markets kicked off the week with a rude shock for recent IPO investors. Four companies—Fractal Analytics, AI Finance, Park Medi World, and Nephrocare Health Services—saw their shares slide significantly on Monday following the expiry of their IPO lock-in periods.
Leading the downturn was AI Finance, whose stock cratered 7.42% after just one month of trading restrictions lifted. This unleashed 17.6 million shares, equivalent to 7% of the firm’s total equity, prompting heavy selling. The stock has now lost over 14% in five sessions and 24% in a month.
Fractal Analytics shares dropped 4.35%, with 6.9 million shares (4% equity) now tradable. Trading at ₹764.35, down 3.98% by early afternoon, it remains 15% off its debut price.
Healthcare plays also faltered: Park Medi World declined 3.2% as 8.5 million shares (2% equity) became available, and Nephrocare Health Services fell 2.8% with 2.8 million shares (3% equity) unlocked.
According to Nuvama Wealth Management, this is just the beginning. Of the 88 companies that went public recently, lock-ins for pre-listing investors end progressively until mid-2026, releasing shares valued at nearly ₹6.6 lakh crore. Such supply surges historically weigh on prices, testing investor resolve.
While short-term holders face headwinds, analysts point out that lock-in expiries often precede consolidation phases. The broader market’s resilience will determine if these dips become buying opportunities or deeper corrections.